Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences to Host an Investor Webcast on June 26, 2025
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
104.04m
Last Price
$3.23
52-Week Range
$2.07 - $4.20
07/01/2025 08:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808